Skip to content
Open access

Harnessing natural RNA triplex elements found in lncRNAs MALAT1 and NEAT1 for engineering of novel riboswitch platforms

Jul 2026 · Nucleic Acids Research · Vol 54 · 1 citation · 73 references
Medicine

TL;DR

A novel riboswitch platform based on RNA triplexes stabilizing non-polyadenylated transcripts while still allowing translation of the respective messenger RNA is presented, designed to function independently of nuclear processes such as transcription and RNA processing.

Abstract

Abstract Synthetic riboswitches are efficient tools to render gene expression inducible by small molecules. Here, we present a novel riboswitch platform based on RNA triplexes stabilizing non-polyadenylated transcripts while still allowing translation of the respective messenger RNA. By incorporating a tetracycline aptamer, we rendered triplex formation dependent upon the presence of the ligand. The new riboswitch platform was able to induce gene expression up to 25-fold as a standalone switch. Combination of the triplex system with an aptazyme placed into the 5′-UTR achieved a 42-fold induction of gene expression. Further, we were able to exchange the triplex, the aptamer, the maturation platform cleaving off the poly-A tail of the switch platform, and the regulated transgene, demonstrating a high degree of modularity. The new riboswitch platform is designed to function independently of nuclear processes such as transcription and RNA processing, potentially expanding the application of these synthetic riboswitches to strictly cytoplasmic therapeutic RNA vectors.

Read PDF

Similar papers

Open access Sep 2026

Massively Parallel In Vitro Functional Analysis of Evolution-Derived Transcriptional Riboswitch Sequences

A high-throughput protocol to characterize the transcriptional activity of nearly 2,000 natural variants of the fluoride riboswitch in in vitro transcription, offering a scalable method for mapping genotype-to-function relationships across transcriptional riboswitch families, accelerating the identification of function...

Laura M. Hertz, Julius B. Lucks · 0 citations
#gene editing Open access Sep 2026

Engineering circular RNA expression systems to minimize contaminating linear RNA byproducts

Circular RNAs (circRNAs) are generated by backsplicing of eukaryotic protein-coding transcripts and can regulate microRNAs and RNA binding proteins, or serve as translation templates. Their covalently closed structure confers resistance to exonuclease-mediated degradation, extending their half-life and supporting their...

Christopher J. Fields, Rina Fujiwara, Bradley W. Wright et al. · 0 citations
Aug 2026

Circular RNA Translation Modulation via Small Ligand-Mediated Protein Stabilization.

A new chemically regulated circRNA translation system based on small ligand-induced stabilization of RNA-binding proteins (RBPs), engineered by incorporating RNA motifs into an internal ribosomal entry site and fusing RBPs with small ligand-stabilized conditional proteins is developed.

Hua Li, Kehui Xin, Li-Juan Tang et al. · 0 citations
#protein folding Open access Sep 2026

Structure-guided antisense oligonucleotides selectively modulate frameshifting of a human gene

This work provides a conceptual and practical framework for targeting recoding-dependent gene products such as PEG10 in disease and suggests broader applicability of structure-directed ASOs to viral and cellular frameshifting elements.

Ondrej Kostov, Myriam Moreno Swanton, Katie R. Waldon et al. · 0 citations
#protein folding Open access Aug 2026

Programmable Enhancement of IRES-Mediated Translation via RNA-Guided eIF4G Recruitment

Internal ribosome entry sites (IRESs) enable cap-independent translation but often exhibit low and variable efficiency, limiting their use in synthetic gene circuits. Here, we present a programmable strategy to enhance IRES-dependent translation by recruiting a truncated eIF4G scaffold via engineered RNA-binding prot...

Bin-Bin Ying, Fei-Yang Zheng, Yoshinori Kawabe et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.